Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

69.56 USD -0.11 (-0.16%)
Official Closing Price Updated: 4:07 PM EST, Dec 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,328,150
Open 70.00
Bid (Size) 69.01 (1)
Ask (Size) 69.69 (3)
Prev. Close 69.67
Today's Range 69.31 - 70.46
52wk Range 56.56 - 73.34
Shares Outstanding 1,253,809,440
Dividend Yield 4.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY, GILD, MRK)
Tags Financial Market Business Finance
From AB Newswire
Gilead’s Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be Highlighted With New Data at SABCS
Gilead Sciences, Inc. (Nasdaq: GILD) will present additional data from the Phase 3 ASCENT study of Trodelvy® (sacituzumab govitecan-hziy) during the upcoming San Antonio Breast Cancer Symposium (SABCS)... 
From Business Wire News Releases

Performance

YTD
+15.72%
+15.72%
1 Month
+3.19%
+3.19%
3 Month
-3.34%
-3.34%
6 Month
+3.16%
+3.16%
1 Year
+14.30%
+14.30%

More News

Read More
Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
From Business Wire News Releases
Trodelvy® (sacituzumab govitecan) Granted European Commission Marketing Authorization for Treatment of Metastatic Triple-Negative Breast Cancer in Second Line
From Business Wire News Releases
4 Biotech Stocks To Watch This Week
Tags Market News
From StockMarket.com
Got $1,000? Check Out These 3 Top Biotech Stocks
Tags BEAM Recent Press Releases VRTX
From Motley Fool
FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
Tags GSK GILD REGN
From MarketWatch
Why Are NRx Pharma's Shares Soaring Premarket?
Tags Movers Market News GILD
From Benzinga
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
Tags BNTX GILD Market News
From Motley Fool
A Look Into Gilead Sciences Debt
Tags Markets BZI/Debt News
From Benzinga
Why NRx Pharmaceuticals Stock Soared Today
Tags Recent Press Releases NRXP GILD
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.